WallStSmart

Acme United Corporation (ACU)vsKenvue Inc. (KVUE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 7437% more annual revenue ($15.29B vs $202.88M). KVUE leads profitability with a 10.6% profit margin vs 4.7%. ACU appears more attractively valued with a PEG of 1.54. KVUE earns a higher WallStSmart Score of 66/100 (B-).

ACU

Buy

50

out of 100

Grade: C-

Growth: 4.0Profit: 5.0Value: 4.0Quality: 8.5
Piotroski: 5/9Altman Z: 3.97

KVUE

Strong Buy

66

out of 100

Grade: B-

Growth: 6.0Profit: 7.0Value: 4.0Quality: 4.5
Piotroski: 4/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

ACUSignificantly Overvalued (-36.1%)

Margin of Safety

-36.1%

Fair Value

$32.18

Current Price

$47.50

$15.32 premium

UndervaluedFair: $32.18Overvalued
KVUESignificantly Overvalued (-87.5%)

Margin of Safety

-87.5%

Fair Value

$9.89

Current Price

$19.78

$9.89 premium

UndervaluedFair: $9.89Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

ACU2 strengths · Avg: 9.0/10
Altman Z-ScoreHealth
3.9710/10

Safe zone — low bankruptcy risk

Price/BookValuation
1.6x8/10

Reasonable price relative to book value

KVUE2 strengths · Avg: 8.0/10
Operating MarginProfitability
21.6%8/10

Strong operational efficiency at 21.6%

EPS GrowthGrowth
46.9%8/10

Earnings expanding 46.9% YoY

Areas to Watch

ACU4 concerns · Avg: 3.3/10
PEG RatioValuation
1.544/10

Expensive relative to growth rate

Market CapQuality
$186.48M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
4.7%3/10

4.7% margin — thin

Operating MarginProfitability
3.3%3/10

Operating margin of 3.3%

KVUE3 concerns · Avg: 3.3/10
PEG RatioValuation
1.604/10

Expensive relative to growth rate

Revenue GrowthGrowth
4.5%4/10

4.5% revenue growth

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : ACU

The strongest argument for ACU centers on Altman Z-Score, Price/Book. Revenue growth of 13.8% demonstrates continued momentum.

Bull Case : KVUE

The strongest argument for KVUE centers on Operating Margin, EPS Growth.

Bear Case : ACU

The primary concerns for ACU are PEG Ratio, Market Cap, Profit Margin. Thin 4.7% margins leave little buffer for downturns.

Bear Case : KVUE

The primary concerns for KVUE are PEG Ratio, Revenue Growth, Altman Z-Score.

Key Dynamics to Monitor

ACU carries more volatility with a beta of 0.51 — expect wider price swings.

ACU is growing revenue faster at 13.8% — sustainability is the question.

KVUE generates stronger free cash flow (350M), providing more financial flexibility.

Monitor HOUSEHOLD & PERSONAL PRODUCTS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

KVUE scores higher overall (66/100 vs 50/100). Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Acme United Corporation

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Acme United Corporation supplies cutting, measuring, first aid, sharpening and safety products for the school, home, office, hardware, sporting goods and industrial markets in the United States, Canada, Europe and Asia. The company is headquartered in Shelton, Connecticut.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Want to dig deeper into these stocks?